Gilead Sciences Inc on Friday said it struck a deal with eight India-based generic drug companies, for them make cheaper copies of Gilead's AIDS drug Viread to be sold in low-income countries.
The Foster City, California-based company said it signed the non-exclusive license deals with Alkem Laboratories Ltd., Aurobindo Pharma Ltd, FDC Ltd., J.B. Chemicals & Pharmaceuticals Ltd., Matrix Laboratories Ltd., Medchem International, Ranbaxy Laboratories Ltd.and Shasun Chemicals & Drugs Ltd.
The deal lets the companies produce and distribute Viread to 95 developing countries, Gilead said.
The move follows a similar agreement with three companies announced in August.
The Foster City, California-based company said it signed the non-exclusive license deals with Alkem Laboratories Ltd., Aurobindo Pharma Ltd, FDC Ltd., J.B. Chemicals & Pharmaceuticals Ltd., Matrix Laboratories Ltd., Medchem International, Ranbaxy Laboratories Ltd.and Shasun Chemicals & Drugs Ltd.
The deal lets the companies produce and distribute Viread to 95 developing countries, Gilead said.
The move follows a similar agreement with three companies announced in August.
posted by doublezero at
12:24 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home